PRCT:NASDAQ, PROCEPT BioRobotics Corporation
PRCT stock overview
PROCEPT BioRobotics Corporation (PRCT:NASDAQ) closed at $19.96 on October 23, 2026,
down 0.35% on the day.
The stock trades 47.6% below its 52-week high of $38.11
and 19.8% above its 52-week low of $16.67.
Over the past year, it lost 43.0%.
PROCEPT BioRobotics Corporation is part of the Health Care sector.
Key figures
- Price
- $19.96
- Day change
- -0.35%
- Volume
- 773,745
- Average volume
- 1,402,145
- Market cap
- 1B+
- 52-week range
- $16.67 – $38.11
- 50-day average
- $19.59
- 200-day average
- $23.70
Price action over the past year
In 252 trading sessions since October 23, 2025, PRCT closed higher on 117 days (46%).
Its best day was March 11, 2026 (+15.02%) and its worst was February 26, 2026 (-15.12%).
The stock moved 10% or more in a single session 7 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
PRCT news
-
Oct 12, 2026:
PROCEPT BioRobotics to Report Third Quarter 2026 Financial Results on November 4th, 2026
-
Oct 12, 2026:
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
-
Oct 8, 2026:
PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change
-
Oct 7, 2026:
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
-
Oct 6, 2026:
Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?
-
Sep 22, 2026:
THINK Surgical Appoints Rick McDowell as Vice President, Sales
-
Sep 17, 2026:
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors With Substantial Losses to Contact the Firm Before September 22, 2026
-
Sep 16, 2026:
Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors That They Have Until September 22, 2026 to Move for Lead Plaintiff
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
Similar stocks
Find more stocks like PRCT with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.